March 23, 2020 / 1:40 PM / 17 days ago

BRIEF-Medexus Provides A Business Update And Outlines Response To Covid-19 Pandemic

March 23 (Reuters) - Medexus Pharmaceuticals Inc:

* MEDEXUS PROVIDES A BUSINESS UPDATE AND OUTLINES RESPONSE TO COVID-19 PANDEMIC

* MEDEXUS PHARMACEUTICALS INC - EXPECTS THAT COVID-19 WILL RESULT IN MEANINGFUL DELAYS IN ENROLLMENT OF PEDIATRIC TRIAL FOR IXINITY

* MEDEXUS PHARMACEUTICALS INC - REVENUE GROWTH IS LIKELY UNATTAINABLE THIS FISCAL YEAR

* MEDEXUS PHARMACEUTICALS INC - BELIEVES IMPACT OF COVID-19 ON ITS PRESCRIPTION DRIVEN BUSINESS WILL BE LIMITED

* MEDEXUS PHARMACEUTICALS INC - EXPECTS DELAY IN IXINITY PEDIATRIC TRIAL TO ENHANCE NEAR TERM CASH FLOW

* MEDEXUS PHARMACEUTICALS INC - COMPLETED A REDUCTION IN ITS WORK FORCE AT TIME OF ITS ACQUISITION OF IXINITY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below